Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.550
-0.050 (-3.13%)
Sep 2, 2026, 3:32 PM EDT - Market open
Imunon Employees
Imunon had 20 employees as of December 31, 2025. The number of employees decreased by 5 or -20.00% compared to the previous year.
Employees
20
Change (1Y)
-5
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$736,658
Market Cap
8.70M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -5 | -20.00% |
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AIM ImmunoTech | 21 |
| IN8bio | 18 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| Immuron | 7 |
| Alzamend Neuro | 6 |
IMNN News
- 7 days ago - IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001 - GlobeNewsWire
- 22 days ago - Imunon Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Imunon Earnings release: Q2 2026 - Filings
- 22 days ago - Imunon Quarterly report: Q2 2026 - Filings
- 22 days ago - Imunon reports Q2 EPS (54c), consensus (50c) - TheFly
- 4 weeks ago - Imunon provides update on OVATION 3 trial of IMNN-001 - TheFly
- 4 weeks ago - IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development - GlobeNewsWire